Pfizer Inc. (PFE)

Index:

S&P 100

$ 22.14
   
  • Change Today:
    $0.10
  • 52 Week High: $31.39
  • 52 Week Low: $21.59
  • Currency: US Dollars
  • Shares Issued: 5,667m
  • Volume: 54,073,683
  • Market Cap: $125,467m
  • RiskGrade: 102
  • Beta: 0.35

Pfizer Overview

In 1849, Charles Pfizer & Company opened as a fine-chemicals business. Now, as a research-based, global pharmaceutical company, Pfizer is the world's largest company devoted to healthcare, with products available in more than 150 countries. In June 2000, Pfizer completed the acquisition of Warner-Lambert, creating the world's most valuable and fastest-growing pharmaceutical company, and, in April 2003, merged with Pharmacia Corporation, enlarging Pfizer's portfolio of consumer healthcare brands and expanding its animal health business.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Pfizer Financials

Latest F'cast
Div Yield 7.6%
Div Cover 0.8
Op Mrgn 12.6%
ROCE 27.8%
Latest F'cast
P/E 15.6
PEG 0.1
Pr/Revenue 2.0
Pr/Book 1.4
Latest F'cast
Revenue 6.8%
PBT 658.3%
EPS 273.7%
DPS 2.4%

Pfizer Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 41,651.00 7,036.00 119.00¢ 30.9 n/a -38% 153.00¢ 4.2%
31-Dec-21 81,288.00 24,311.00 400.00¢ 14.8 0.1 +236% 157.00¢ 2.7%
31-Dec-22 100,330.00 34,729.00 559.00¢ 9.2 0.2 +40% 161.00¢ 3.1%
31-Dec-23 59,553.00 1,058.00 38.00¢ 75.8 n/a -93% 165.00¢ 5.7%
31-Dec-24 63,627.00 8,023.00 142.00¢ 18.7 0.1 +274% 169.00¢ 6.4%

Pfizer Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 63,029.42 21,724.62 295.48¢ 7.5 0.1 +108% 170.72¢ 0.0%
31-Dec-26 62,938.64 21,944.93 303.74¢ 7.3 2.6 +3% 171.70¢ 0.0%
31-Dec-27 61,870.01 21,423.51 299.49¢ 7.4 n/a -1% 174.68¢ 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Pfizer ShareCast News

US close: Stocks slide on automotive tariff conc... 27-Mar-2025 ShareCast
Pfizer pares back Haleon stake in £2.5bn sale 15-Jan-2025 ShareCast
Pfizer meets forecasts with 2025 guidance 17-Dec-2024 ShareCast

Pfizer Top Newspaper Links

Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
Some reasons why Pfizer won’t bid for AstraZenec... 19-Nov-2014 Guardian
Pfizer unlikely to try AstraZeneca takeover agai... 07-Nov-2014 Guardian

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Pfizer Market Data

Currency US Dollars
Share Price $ 22.14
Change Today $ 0.10
% Change 0.45 %
52 Week High $31.39
52 Week Low $21.59
Volume 54,073,683
Shares Issued 5,667m
Market Cap $125,467m
Beta 0.35
RiskGrade 102

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 14
Sell 0
Strong Sell 1
Total 21
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 17-Apr-2025

Time Volume / Share Price
15:59 100 @ $22.14
15:59 764 @ $22.15
15:59 200 @ $22.14
15:59 300 @ $22.15
15:59 1,100 @ $22.14

Top of Page